Insecticides (India) Ltd. News and Updates

Name: Latest research reports of Insecticides (India) Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Insecticides (India) Ltd.
Rating: 5
Author: Prabhudas Lilladhar

Keep track of all breaking news on Insecticides (India) Ltd. from all sources in a single place.

Load latest

Insecticides (India) Ltd.

18 Oct 2019

747.70

-0.16%

Insecticides India launches Japanese miticide product

Business Line

Mites can cause huge losses to farmers, but farmers require multiple products to tackle these pests at different stages of its lifecycle. "Though ther

Insecticides (India) Ltd. is trading below all available SMAs

Insecticides (India) Ltd.

31 May 2019, 12:00AM

747.70

-0.16%

Q4FY19 Result Update

Buy: Insecticides (India) Ltd.

Prabhudas Lilladhar

INST's outperformance vis--vis domestic industry continued in Q4FY19 with Change in Estimates | Target | Reco topline/EBITDA/PBT growth of 18%/55%/62% YoY, driven by new launches. Led by its strong product pipeline, this performance is expected to sustain...

Number of FII/FPI investors increased from 50 to 57 in Jun 2025 qtr.

Insecticides (India) Ltd.

30 May 2019, 04:32PM

747.70

-0.16%

Insecticides (India) to invest Rs 15 cr in export oriented unit in Gujarat

Business Standard

The listed agrochemicals firm will also invest Rs 100 crore in brownfield projects

Insecticides (India) Ltd. has gained 26.55% in the last 6 Months

Insecticides (India) Ltd.

17 Feb 2019

747.70

-0.16%

Insecticides India: Revival in growth

Business Line

Pick-up in demand from overseas markets and new launches work in favour of the company

Insecticides (India) Ltd. has gained 26.55% in the last 6 Months

Insecticides (India) Ltd.

13 Nov 2018

747.70

-0.16%

Insecticides India (2QFY19): Flurry of new products. Maintain BUY

Buy: Insecticides (India) Ltd.

Target

HDFC Securities

Maintain BUY with a TP of Rs 960/sh (17x Sept-20 EPS). Insecticides Indias (INST) reported a healthy 2QFY19 performance amidst rupee depreciation and higher input costs (technicals). Sales/EBITDA/PAT grew by 10.0/24.4/18.9% YoY to Rs 4.5bn/Rs 692mn/Rs 430 mn respectively.

Insecticides (India) Ltd. is trading below all available SMAs

Insecticides (India) Ltd.

09 Aug 2018

747.70

-0.16%

Insecticides India (1QFY19): Striking the right chord. Maintain BUY

Buy: Insecticides (India) Ltd.

Target

HDFC Securities

Maintain BUY with a TP of Rs 937/sh (17x Jun'20 EPS). Insecticides Indias (INST) 1QFY19 revenue was at Rs 3.1bn (up 2.3% YoY). Revenue growth was muted due to lower concentration of Generic products in the mix. Change in the product mix led to strong EBITDA margin of 17.4% (up 122 bps), and EBITDA coming in at Rs 556mn (up 10.0% YoY). PAT came in at Rs 340mn, with a higher tax rate of 29.3% (against 27.6% in 1QFY18).

Insecticides (India) Ltd. has lost -22.75% in the last 3 Months

Insecticides (India) Ltd.

01 Jun 2018

747.70

-0.16%

Insecticides (India) plans 200-crore expansion

Business Line

To set up export unit in Gujarat

Insecticides (India) Ltd. is trading below all available SMAs

Insecticides (India) on 200 cr expansion

Business Line | 01 Jun 2018, 02:57PM

Insecticides (India) Ltd.

29 May 2018

747.70

-0.16%

Insecticides India (4QFY18): Betting on new launches. Maintain BUY

Buy: Insecticides (India) Ltd.

Target

HDFC Securities

INST's long-term story remains intact; however the rise in raw material costs may lead to pressure on margins, hence we have marginally reduced our earnings estimates for FY19E/20E by 3.3/1.4% respectively. Accordingly reduced the target price to Rs 914 (vs. Rs 927) (17x FY20E EPS). Insecticides Indias (INST) reported muted results for 4QFY18; revenues stood at Rs 1.68bn (+2.5% YoY), largely driven by volume growth. The introduction of few specialty products led to an improvement in gross margins by 394bps YoY to 31.0%. Consequently, EBITDA grew by 55.2% YoY to Rs 187mn, and EBITDAM improved by 375bps to 11.0% for the quarter.

Insecticides (India) Ltd. has gained 26.55% in the last 6 Months

Insecticides (India) Ltd.

08 Feb 2018

747.70

-0.16%

Insecticides India (3QFY18): Beat on volume growth. Upgrade to BUY

Buy: Insecticides (India) Ltd.

Recommendation Target

HDFC Securities

We upgraded our earnings estimates for FY19/20 by 5.0/4.8% respectively. We recommend BUY with a TP of Rs 893/sh (17x Dec FY19E EPS). Insecticides Indias (INST) reported good results for 3QFY18; revenues stood at Rs 1.75bn (+24.0% YoY). The growth was largely on account of 20% volume growth and rest from the price hike. The introduction of certain specialty products led to an improvement in gross margins by 190bps YoY to 31.3%. Consequently, EBITDA grew by 35.5% YoY to Rs 230mn, and EBITDAM improved by 111bps to 13.1% for the quarter. Lower interest cost (-18.1% YoY) led APAT to grow by 67.4% YoY to Rs 96mn.

Insecticides (India) Ltd. has lost -22.75% in the last 3 Months

Insecticides (India) Ltd.

04 Dec 2017

747.70

-0.16%

INSECTICIDES INDIA LIMITED

Buy: Insecticides (India) Ltd.

Joindre Capital Services

Insecticides India Limited (IIL) which commenced op erations in 2001, has eme rged as an integr ated play er in the Indian agrochemicals market by entering into global tie- ups. With state-of -the-art R&D; f acilities and manuf acturing units, and a strong portf olio (99 products), IIL enjoy s a 7% share in the domestic market. IIL has a product portf olio of ov er 120 f ormulations and enjoy s a Pan India presence of ov er 5000 distributors, 60000 dealers and ov er 30 depots. IIL is a generic play er in the A gri chemicals space with 348 r egistrations and a v aried portf olio of 99 f ormulations and 18 Technicals. It has ov er the y ears dev eloped generic pr oducts under the Tractor Br and n ame. 75% of its business comprises of branded sales while 25% is B2B/Institutional sales IIL has 7 f ormulation manuf acturing assets across India with one R&D; centre and technical plant in Rajasthan and...